Skip to main content
logo
Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
6.34
+0.07 (1.12%)
At close: Jun 12, 2026, 4:00 PM EDT
6.35
0.00 (0.08%)
After-hours: Jun 12, 2026, 4:10 PM EDT

Journey Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-9.59-11.43-14.67-3.85-29.63-43.99
Depreciation & Amortization
4.414.353.523.864.372.56
Stock-Based Compensation
5.956.296.12.614.432.47
Other Adjustments
0.090.26-0.34.291.1222.08
Change in Receivables
-6.59-19.344.4812.55-5.380.77
Changes in Inventories
3.24.81-4.233.951.74-8.42
Changes in Accounts Payable
-6.2-7.2-2.1-18.4214.3420.39
Changes in Accrued Expenses
3.1110.14-2.540.82-3.461.24
Changes in Income Taxes Payable
0.010.010.010.020.03-0.09
Changes in Other Operating Activities
-0.79-0.320.62-0.58-1.140.87
Operating Cash Flow
-0.42-12.44-9.135.24-13.53-2.18
Purchases of Intangible Assets
---15-5-20-10
Investing Cash Flow
---15-5-20-10
Short-Term Debt Issued
---2857
Short-Term Debt Repaid
----30.95-2.86-6.19
Net Short-Term Debt Issued (Repaid)
----2.952.140.81
Long-Term Debt Issued
--101519.769.54
Long-Term Debt Repaid
--0.63-1.25-21-5-5.3
Net Long-Term Debt Issued (Repaid)
--0.638.75-614.764.24
Issuance of Common Stock
12.9216.938.294.620.1432.54
Net Common Stock Issued (Repurchased)
12.9216.938.294.620.1432.54
Issuance of Preferred Stock
-----18.97
Net Preferred Stock Issued (Repurchased)
-----18.97
Other Financing Activities
--0.08-0.05-0.47-0.59-3.55
Financing Cash Flow
12.8516.2316.99-4.816.4653.02
Net Cash Flow
6.153.79-7.13-4.56-17.0840.84
Free Cash Flow
-0.42-12.44-9.135.24-13.53-2.18
FCF Margin
-0.84%-20.11%-16.26%6.62%-18.37%-3.45%
Free Cash Flow Per Share
-0.02-0.51-0.450.29-0.77-0.21
Levered Free Cash Flow
-5.85-0.27-10.65-23.153.15-22.41
Unlevered Free Cash Flow
-2.643.57-18.46-12.55-11.7-19.69
SEC Filings: 10-K · 10-Q